vendredi 17 juillet 2015

Onco Actu du 17 juillet 2015

1. Biologie

Can protein 14-3-3 sigma prevent or kill breast cancer tumors? [MD Anderson Cancer Center]

Scientists solve breast and ovarian cancer genetic mystery [Cancer Research UK]

4.9 Dép., diag. & prono. - Sein

How To Avoid Overdiagnosis And Overtreatment Of Breast Cancer [Forbes]

5. Traitements

Proton beam therapy: where are we now? [Cancer Research UK]

5.2 Pharma

Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia [Amgen]

Immunocore Raises $320M Toward ImmTAC Development | GEN News Highlights [GEN]

T-cell pioneer Immunocore scores a record-breaking $320M round [FierceBiotech]

How Servier saved Cellectis, the French CAR-T Miracle []

Amgen reports positive preliminary results on leukemia drug [Reuters]

5.2.1 Pharma - Partenariats

Five Prime bets up to $452.5M on Inhibrx's cancer antibodies [Fierce Biotech]

5.3 Traitements - FDA, EMA,...

AB Science hit with FDA warning letter over clinical trials [Outsourcing Pharma]

6.1 Observation

Blacks may be less likely to get chemo for advanced colon cancer [Reuters]

6.11 Patients

Living With Cancer: Curses and Blessings [NY Times]

6.6 Publications

Skewering the impact factor [Responsible Metrics]

When Do Citations Reflect “Impact?” [The Scholarly Kitchen]

6.9 Controverses

Collaborate and listen to reproduce research [Nature News & Comment]